Quest Diagnostics Incorporated - stock earnings
DGX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 23, 2024 AfterMarket | 2.04 / 1.87 | 2.2 billion | - / 2.3 billion | 2.3 billion |
DGX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 192.0 million USD | 2.3 billion USD |
| 2023Q3 | 225.0 million USD | 2.3 billion USD |
| 2023Q2 | 235.0 million USD | 2.3 billion USD |
| 2023Q1 | 202.0 million USD | 2.3 billion USD |
| 2022Q4 | 101.0 million USD | 2.3 billion USD |
| 2022Q3 | 254.0 million USD | 2.5 billion USD |
| 2022Q2 | 233.0 million USD | 2.5 billion USD |
| 2022Q1 | 354.0 million USD | 2.6 billion USD |
| 2021Q4 | 390.0 million USD | 2.7 billion USD |
| 2021Q3 | 505.0 million USD | 2.8 billion USD |
| 2021Q2 | 631.0 million USD | 2.6 billion USD |
| 2021Q1 | 469.0 million USD | 2.7 billion USD |
| 2020Q4 | 579.0 million USD | 3.0 billion USD |
| 2020Q3 | 568.0 million USD | 2.8 billion USD |
| 2020Q2 | 185.0 million USD | 1.8 billion USD |
| 2020Q1 | 99.0 million USD | 1.8 billion USD |
| 2019Q4 | 253.0 million USD | 1.9 billion USD |
| 2019Q3 | 215.0 million USD | 2.0 billion USD |
| 2019Q2 | 226.0 million USD | 2.0 billion USD |
| 2019Q1 | 164.0 million USD | 1.9 billion USD |
| 2018Q4 | 127.0 million USD | 1.8 billion USD |
| 2018Q3 | 213.0 million USD | 1.9 billion USD |
| 2018Q2 | 219.0 million USD | 1.9 billion USD |
| 2018Q1 | 177.0 million USD | 1.9 billion USD |
| 2017Q4 | 254.0 million USD | 1.9 billion USD |
| 2017Q3 | 161.0 million USD | 1.9 billion USD |
| 2017Q2 | 193.0 million USD | 1.9 billion USD |
| 2017Q1 | 164.0 million USD | 1.9 billion USD |
| 2016Q4 | 155.0 million USD | 1.9 billion USD |
| 2016Q3 | 192.0 million USD | 1.9 billion USD |
| 2016Q2 | 195.0 million USD | 1.9 billion USD |
| 2016Q1 | 102.0 million USD | 1.9 billion USD |
| 2015Q4 | 188.0 million USD | 1.8 billion USD |
| 2015Q3 | 342.0 million USD | 1.9 billion USD |
| 2015Q2 | 118.0 million USD | 1.9 billion USD |
| 2015Q1 | 61.0 million USD | 1.8 billion USD |
| 2014Q4 | 190.0 million USD | 1.9 billion USD |
| 2014Q3 | 129.0 million USD | 1.9 billion USD |
| 2014Q2 | 133.0 million USD | 1.9 billion USD |
| 2014Q1 | 104.0 million USD | 1.7 billion USD |
| 2013Q4 | 143.0 million USD | 1.8 billion USD |
| 2013Q3 | 405.1 million USD | 1.8 billion USD |
| 2013Q2 | 165.5 million USD | 1.8 billion USD |
| 2013Q1 | 135.8 million USD | 1.8 billion USD |
| 2012Q4 | 55.8 million USD | 1.8 billion USD |
| 2012Q3 | 163.1 million USD | 1.9 billion USD |
| 2012Q2 | 177.7 million USD | 1.9 billion USD |
| 2012Q1 | 159.1 million USD | 1.9 billion USD |
| 2011Q4 | 189.4 million USD | 1.9 billion USD |
| 2011Q3 | 171.8 million USD | 1.9 billion USD |
| 2011Q2 | 163.1 million USD | 1.9 billion USD |
| 2011Q1 | 140.8 million USD | 1.8 billion USD |
| 2010Q4 | 165.8 million USD | 1.8 billion USD |
| 2010Q3 | 198.0 million USD | 1.9 billion USD |
| 2010Q2 | 194.7 million USD | 1.9 billion USD |
| 2010Q1 | 162.4 million USD | 1.8 billion USD |
| 2009Q4 | 181.6 million USD | 1.8 billion USD |
| 2009Q3 | 192.2 million USD | 1.9 billion USD |
| 2009Q2 | 188.2 million USD | 1.9 billion USD |
| 2009Q1 | 175.7 million USD | 1.8 billion USD |
| 2008Q4 | 169.8 million USD | 1.8 billion USD |
| 2008Q3 | 110.7 million USD | 1.8 billion USD |
| 2008Q2 | 161.3 million USD | 1.8 billion USD |
| 2008Q1 | 139.6 million USD | 1.8 billion USD |
| 2007Q4 | -5.3 million USD | 1.8 billion USD |
| 2007Q3 | 98.0 million USD | 1.8 billion USD |
| 2007Q2 | 141.3 million USD | 1.6 billion USD |
| 2007Q1 | 105.9 million USD | 1.5 billion USD |
| 2006Q4 | 149.3 million USD | 1.5 billion USD |
| 2006Q3 | 160.5 million USD | 1.6 billion USD |
| 2006Q2 | 132.0 million USD | 1.6 billion USD |
| 2006Q1 | 144.6 million USD | 1.6 billion USD |
| 2005Q4 | 130.3 million USD | 1.4 billion USD |
| 2005Q3 | 135.2 million USD | 1.4 billion USD |
| 2005Q2 | 149.1 million USD | 1.4 billion USD |
| 2005Q1 | 131.6 million USD | 1.3 billion USD |
| 2004Q4 | 126.1 million USD | 1.3 billion USD |
| 2004Q3 | 130.1 million USD | 1.3 billion USD |
| 2004Q2 | 126.8 million USD | 1.3 billion USD |
| 2004Q1 | 116.1 million USD | 1.3 billion USD |
| 2003Q4 | 108.2 million USD | 1.2 billion USD |
| 2003Q3 | 120.0 million USD | 1.2 billion USD |
| 2003Q2 | 120.4 million USD | 1.2 billion USD |
| 2003Q1 | 88.0 million USD | 1.1 billion USD |
| 2002Q4 | 81.7 million USD | 1.0 billion USD |
| 2002Q3 | 86.6 million USD | 1.1 billion USD |
| 2002Q2 | 87.2 million USD | 1.1 billion USD |
| 2002Q1 | 66.7 million USD | 946.8 million USD |
| 2001Q4 | 50.9 million USD | 910.4 million USD |
| 2001Q3 | 50.1 million USD | 903.2 million USD |
| 2001Q2 | 25.5 million USD | 931.6 million USD |
| 2001Q1 | 25.4 million USD | 836.3 million USD |
| 2000Q4 | 25.4 million USD | 836.3 million USD |
| 2000Q3 | 28.7 million USD | 850.2 million USD |
| 2000Q2 | 30.2 million USD | 877.1 million USD |
| 2000Q1 | 17.8 million USD | 857.5 million USD |
| 1999Q4 | -14.5 million USD | 814.5 million USD |
| 1999Q3 | -9.4 million USD | 614.8 million USD |
| 1999Q2 | 13.1 million USD | 394.0 million USD |
| 1999Q1 | 7.4 million USD | 381.8 million USD |
| 1998Q4 | 5.4 million USD | 363.3 million USD |
| 1998Q3 | 6.1 million USD | 360.7 million USD |
| 1998Q2 | 8.9 million USD | 366.7 million USD |
| 1998Q1 | 6.6 million USD | 367.9 million USD |
| 1997Q4 | -37.4 million USD | 365.4 million USD |
| 1997Q3 | 3.0 million USD | 373.6 million USD |
| 1997Q2 | 8.1 million USD | 401.5 million USD |
| 1997Q1 | 4.0 million USD | 388.1 million USD |
| 1996Q4 | -467.1 million USD | 385.0 million USD |
| 1996Q3 | -119.4 million USD | 405.4 million USD |
DGX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 854.0 million USD | 9.3 billion USD |
| 2022 | 946.0 million USD | 9.9 billion USD |
| 2021 | 2.0 billion USD | 10.8 billion USD |
| 2020 | 1.4 billion USD | 9.4 billion USD |
| 2019 | 858.0 million USD | 7.7 billion USD |
| 2018 | 736.0 million USD | 7.5 billion USD |
| 2017 | 772.0 million USD | 7.7 billion USD |
| 2016 | 645.0 million USD | 7.5 billion USD |
| 2015 | 709.0 million USD | 7.5 billion USD |
| 2014 | 556.0 million USD | 7.4 billion USD |
| 2013 | 849.0 million USD | 7.1 billion USD |
| 2012 | 555.7 million USD | 7.4 billion USD |
| 2011 | 470.6 million USD | 7.5 billion USD |
| 2010 | 720.9 million USD | 7.4 billion USD |
| 2009 | 729.1 million USD | 7.5 billion USD |
| 2008 | 581.5 million USD | 7.2 billion USD |
| 2007 | 339.9 million USD | 6.7 billion USD |
| 2006 | 586.4 million USD | 6.3 billion USD |
| 2005 | 546.3 million USD | 5.5 billion USD |
| 2004 | 499.2 million USD | 5.1 billion USD |
| 2003 | 436.7 million USD | 4.7 billion USD |
| 2002 | 322.2 million USD | 4.1 billion USD |
| 2001 | 162.3 million USD | 3.6 billion USD |
| 2000 | 102.1 million USD | 3.4 billion USD |
| 1999 | -3.4 million USD | 2.2 billion USD |
| 1998 | 26.9 million USD | 1.5 billion USD |
| 1997 | -22.3 million USD | 1.5 billion USD |
| 1996 | -626.0 million USD | 1.6 billion USD |
DGX
List: Contenders
Price: $135.42
52 week price:
Dividend Yield: 0.02%
5-year range yield:
Forward Dividend Yield: 2.22%
Payout Ratio: 40.05%
Payout Ratio Range:
Dividend Per Share: 3.00 USD
Earnings Per Share: 7.49 USD
P/E Ratio: 17.05
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.3 million
Ebitda: 346.0 millionMarket Capitalization: 14.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 21
DGR3: 7.59%
DGR5: 6.76%
DGR10: 8.22%